A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer.

NCT05346146 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Unresectable Locally Advanced Pancreatic Cancer

Interventions

DRUG: Sintilimab; Gemcitabine; Albumin-paclitaxel

Sponsor

RenJi Hospital

Collaborators

[object Object]